04/22/2025
3:25 PM | Aprea Therapeutics (Filer)
| Form ARS | |
04/08/2025
2:14 PM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
04/04/2025
6:30 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
3:31 PM | Aprea Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
7:45 AM | Aprea Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
11:15 AM | Aprea Therapeutics (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
11:56 AM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
7:36 AM | Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
7:30 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for APRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
3:53 PM | Aprea Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/07/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:38 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
4:42 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
7:30 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
8:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:15 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:16 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:17 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:18 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:19 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
3:15 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2024
3:16 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy APRE Stock Free APRE Stock Alerts